Noriyuki Kasahara - Sep 23, 2022 Form 3 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Director
Signature
/s/ August J. Moretti, Attorney-in-Fact for Noriyuki Kasahara
Stock symbol
FDMT
Transactions as of
Sep 23, 2022
Transactions value $
$0
Form type
3
Date filed
9/27/2022, 05:00 PM
Next filing
May 25, 2023

No securities are beneficially owned.